Phenylbutenamine
| Clinical data | |
|---|---|
| Other names | 4-Phenylbut-3-en-2-amine; 1-Methyl-3-phenylprop-2-enylamine; PAL-881/PAL-893 |
| Drug class | Norepinephrine–dopamine releasing agent |
| Identifiers | |
| |
| PubChem CID | |
| ChemSpider | |
| Chemical and physical data | |
| Formula | C10H13N |
| Molar mass | 147.221 g·mol−1 |
| 3D model (JSmol) | |
| |
| |
Phenylbutenamine, or 4-phenylbut-3-en-2-amine, is a monoamine releasing agent (MRA) of the arylalkylamine family related to β-phenethylamine and amphetamine. It has two possible stereoisomers: (3E)-phenylbutenamine (PAL-881) and (3Z)-phenylbutenamine (PAL-893). Both of these enantiomers act as norepinephrine–dopamine releasing agents (NDRAs), and to similar comparative extents, albeit with far lower potency than β-phenethylamine or amphetamine.